In 2017, 80% of the people who needed treatment at a specialty facility for illicit drug use didn’t receive treatment.1 The links below provide evidence-based information on practice guidance, buprenorphine waiver training, emergency department treatment, and overdose treatment. Starting in January 2020, the Centers for Medicare & Medicaid Services (CMS) will pay Opioid Treatment Programs for opioid use disorder treatment services provided to people with Medicare Part B. Visit the CMS website to learn more.
- OUD Treatments and Practice Guidance
- Science to Medicine: Medication Treatment for Opioid Use Disorder
- Effective Treatments for Opioid Addiction
- Medications to Treat Opioid Addiction
- National Guidelines for the Use of Medications in the Treatment of Addiction Involving Opioid Use
- Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants
- SAMHSA’s Providers Clinical Support System — Get access to training and mentoring programs for preventing, identifying, and treating opioid use disorders.
- About Buprenorphine, Waiver Training, and Certification
- About Buprenorphine
- Qualifications to obtain your waiver
- Treatment of Opioid Use Disorder: Waiver Qualifying
- Study: Buprenorphine Benefits Waitlisted Seekers of Opioid Treatment
- Study: Comparison of OUD treatments highlights effectiveness of methadone and buprenorphine
- Emergency and Overdose Treatment
- Treatment in the Emergency Department
- Science to Medicine: MAT in the ED – Review the latest science on medication treatment and read about how two physicians have integrated treatment into the Emergency Department
- Initiating Buprenorphine Treatment in the Emergency Department – Research-based tools, tips from providers, videos, and patient handouts
- Emergency Medicine Initiative (Addiction Policy Forum)
Visit the NIDAMED CME/CE page for trainings on treatment for opioid use disorder and opioid overdose.
More Treatment Resources
- Substance Abuse and Mental Health Services Administration. (2018). Key substance use and mental health indicators in the United States: Results from the 2017 National Survey on Drug Use and Health (HHS Publication No. SMA 18-5068, NSDUH Series H-53). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHDetailedTabs2017/NSDUHDetailedTabs2017.htm#tab5-46B